Skip to main content
Premium Trial:

Request an Annual Quote

Taking the Conflict-of-Interest Heat

University of Wisconsin-Madison cancer researcher Minesh Mehta has resigned his post after the school started investigating a possible conflict of interest in his dealings with a device maker, the Wisconsin State Journal's Doug Erickson reports. In April, UW starting looking into Mehta's relationship with TomoTherapy, which makes cancer treatment devices. For almost 10 years, Erickson says, Mehta has been the lead researcher on a clinical trial for a specialized radiation treatment for cancer patients — the device used in the majority of the study is made by TomoTherapy, for which Mehta is a consultant. Mehta, who turned in his resignation in May, says there is no conflict of interest and that the investigation had nothing to do with why he resigned, although he did so without having lined up another job. In 2009, Erickson says, TomoTherapy paid Mehta more than $20,000 in compensation and more than $10,000 in stock options for about 20 days of consulting work.

HT: The Chronicle of Higher Education

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.